Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BIOLARGO, INC. (BLGO)
|
Add to portfolio |
|
|
|
| Price: |
$0.22
| | Metrics |
| OS: |
288.1
|
M
| |
-77
|
% ROE
|
| Market cap: |
$62.8
|
M
| |
-204
|
% ROIC
|
|
Net cash:
|
$3.21
|
M
| |
$0.01
|
per share
|
|
EV:
|
$59.6
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($4.1)
|
M
| |
|
|
|
EBIT
|
($4.2)
|
M
| |
|
|
| EPS |
($0.01)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 5.9 | 2.5 | 1.9 | 1.4 | 0.5 | 0.3 | 0.1 | -0.2 |
| Revenue growth | 132.5% | | 36.4% | 164.3% | 83.6% | 120.3% | -153.9% | -240.9% |
| Cost of goods sold | 3.0 | 1.4 | 0.9 | 0.7 | 0.0 | 0.1 | 0.1 | 0.1 |
| Gross profit | 2.9 | 1.1 | 0.9 | 0.6 | 0.5 | 0.2 | 0.1 | -0.3 |
| Gross margin | 48.6% | 43.6% | 49.2% | 45.5% | 100.0% | 62.3% | 51.4% | 123.7% |
| Selling, general and administrative | 6.7 | 6.2 | 6.1 | 5.3 | 4.4 | 3.7 | 3.6 | 2.8 |
| Research and development | 1.3 | 1.4 | 1.5 | 1.7 | 1.6 | 1.4 | 0.7 | 0.6 |
| EBITA | -5.2 | -6.4 | -6.7 | -6.4 | -5.9 | -4.9 | -4.2 | -3.4 |
| EBITA margin | -88.3% | -254.3% | -359.8% | -470.1% | -1142.6% | -1751.6% | -3268.9% | 1428.7% |
| Amortization of intangibles | | | | | | 0.0 | 0.0 | 0.0 |
| EBIT | -5.2 | -6.4 | -6.7 | -6.4 | -5.9 | -4.9 | -4.2 | -3.4 |
| EBIT margin | -88.3% | -254.3% | -359.8% | -470.1% | -1142.6% | -1755.5% | -3277.5% | 1433.4% |
| Pre-tax income | -5.1 | -6.9 | -11.4 | -10.7 | -9.5 | -8.1 | -5.1 | -3.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -4.5 | -7.1 | -10.7 | -10.2 | -9.1 | -7.8 | -5.1 | -3.7 |
| Net margin | -76.0% | -279.7% | -574.4% | -749.3% | -1767.1% | -2788.9% | -3962.9% | 1560.4% |
| |
| Diluted EPS | ($0.02) | ($0.03) | ($0.07) | ($0.08) | ($0.09) | ($0.09) | ($0.06) | ($0.05) |
| Shares outstanding (diluted) | 268.3 | 247.2 | 152.1 | 122.0 | 98.9 | 87.9 | 84.1 | 80.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|